Login / Signup

Design and Synthesis of Oligopeptidic Parvulin Inhibitors.

Nicola RelittiAkella Prasanth SaraswatiGabriele CarulloAlessandro PapaAlessandra MontiRosaria BenedettiEugenia PassaroSimone BrogiVincenzo CalderoneStefania ButiniSandra GemmaLucia AltucciGiuseppe CampianiNunzianna Doti
Published in: ChemMedChem (2022)
Pin1 catalyzes the cis-trans isomerization of pThr-Pro or pSer-Pro amide bonds of various proteins involved in several physio/pathological processes. In this framework, recent research activity is directed toward the identification of new selective Pin1 inhibitors. Here, we developed a set of peptide-based Pin1 inhibitors. Direct-binding experiments allowed the identification of the peptide-based inhibitor 5 k (methylacetyl-l-alanyl-l-histidyl-l-prolyl-l-phenylalaninate) as a potent ligand of Pin1. Notably, 5 k binds Pin1 with higher affinity than Pin4. The comparative analysis of molecular models of Pin1 and Pin4 with the selected compound gave a rational explanation of the biochemical activity and pinpointed the chemical elements that, if opportunely modified, may further improve inhibitory potency, pharmacological properties, and selectivity of future peptide-based parvulin inhibitors. Since 5 k showed limited cell penetration and no antiproliferative activity, it was conjugated to a polyarginine stretch (R8), known to promote cell penetration of peptides, to obtain the R8-5 k derivative, which displayed antiproliferative effects on cancer cell lines over non-tumor cells. The effect of R8 on cell proliferation was also investigated. This work warrants caution about applying the R8 strategy in the development of cell-penetrating antiproliferative peptides, as it is not inert.
Keyphrases
  • single cell
  • cell proliferation
  • cell therapy
  • anti inflammatory
  • high resolution
  • current status
  • structural basis